Brett Staahl Scientist and biotechnology founder developing CRISPR-based genetic medicines. Before co-founding Scribe Therapeutics, he was a postdoctoral fellow in Jennifer Doudna's lab and pioneered delivery methods for CRISPR ribonucleoproteins.
Brett Staahl Scientist and biotechnology founder developing CRISPR-based genetic medicines. Before co-founding Scribe Therapeutics, he was a postdoctoral fellow in Jennifer Doudna's lab and pioneered delivery methods for CRISPR ribonucleoproteins.
Career
Co-founder and VP of External Innovation at Scribe Therapeutics from 2018 to Present